The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

10 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Potent, Selective, and Cell Active Protein Arginine Methyltransferase 5 (PRMT5) Inhibitor Developed by Structure-Based Virtual Screening and Hit Optimization.EBI
Shandong University
Recent advances in nuclear receptor-binding SET domain 2 (NSD2) inhibitors: An update and perspectives.EBI
China Pharmaceutical University
NSD3: Advances in cancer therapeutic potential and inhibitors research.EBI
Peking University
Drug Discovery Targeting Nuclear Receptor Binding SET Domain Protein 2 (NSD2).EBI
University of Texas Medical Branch (UTMB)
Discovery of a New-Generation S-Adenosylmethionine-Noncompetitive Covalent Inhibitor Targeting the Lysine Methyltransferase Enhancer of Zeste Homologue 2.EBI
Sun Yat-Sen University
Discovery of cysteine-targeting covalent histone methyltransferase inhibitors.EBI
Nanjing Medical University
Structural Modification and Pharmacological Evaluation of Substituted Quinoline-5,8-diones as Potent NSD2 Inhibitors.EBI
Shanghai Jiao Tong University
From Hit Seeking to Magic Bullets: The Successful Union of Epigenetic and Fragment Based Drug Discovery (EPIDD + FBDD).EBI
University of S£O Paulo
5-Aminonaphthalene derivatives as selective nonnucleoside nuclear receptor binding SET domain-protein 2 (NSD2) inhibitors for the treatment of multiple myeloma.EBI
Chinese Academy of Sciences
An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of EED.BDB
Novartis Institutes For Biomedical Research